← Eichor
Condition: Mixed Dyslipidemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mixed Dyslipidemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study
NA · 1 location(s) · Alexandra Hospital · NCT06752772IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Phase 3 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07473960A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
Phase N/A · 1 location(s) · Boryung Pharmaceutical Co., Ltd · NCT06314919A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia
Phase 2 · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07695597Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Phase 3 · 1 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT05621070A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholes
Phase 3 · 2 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07421297Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia
Phase 2 · 4 location(s) · Ribocure Pharmaceuticals AB · NCT06797401A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · 163 location(s) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615A Study to Evaluate the Efficacy and Safety of AD-218
Phase 3 · 1 location(s) · Addpharma Inc. · NCT05400317A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Phase 1 · 19 location(s) · CRISPR Therapeutics AG · NCT07491172A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A
Phase 1 · 1 location(s) · Addpharma Inc. · NCT06932705Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia
Phase 1/Phase 2 · 15 location(s) · Arrowhead Pharmaceuticals · NCT07223658Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)
Phase N/A · 4 location(s) · Novartis Pharmaceuticals · NCT06770543Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipide
Phase 3 · 1 location(s) · A. Menarini International Licensing S.A. · NCT07614958A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Phase 3 · 18 location(s) · Hasten Biopharmaceutical Co., Ltd. · NCT06568471Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
NA · 1 location(s) · Indiana University · NCT07119658
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.